annual cash & cash equivalents:
$180.43M-$270.74M(-60.01%)Summary
- As of today (June 17, 2025), MLTX annual cash & cash equivalents is $180.43 million, with the most recent change of -$270.74 million (-60.01%) on December 31, 2024.
- During the last 3 years, MLTX annual cash & cash equivalents has risen by +$172.39 million (+2144.44%).
- MLTX annual cash & cash equivalents is now -60.01% below its all-time high of $451.17 million, reached on December 31, 2023.
Performance
MLTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$271.57M+$91.14M(+50.51%)Summary
- As of today (June 17, 2025), MLTX quarterly cash & cash equivalents is $271.57 million, with the most recent change of +$91.14 million (+50.51%) on March 31, 2025.
- Over the past year, MLTX quarterly cash & cash equivalents has dropped by -$186.88 million (-40.76%).
- MLTX quarterly cash & cash equivalents is now -45.88% below its all-time high of $501.79 million, reached on June 30, 2023.
Performance
MLTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MLTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.0% | -40.8% |
| 3 y3 years | +2144.4% | - |
| 5 y5 years | +2144.4% | - |
MLTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.0% | +2144.4% | -45.9% | +587.4% |
| 5 y | 5-year | -60.0% | +2144.4% | -45.9% | +3278.2% |
| alltime | all time | -60.0% | +2144.4% | -45.9% | +3278.2% |
MLTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $271.57M(+50.5%) |
| Dec 2024 | $180.43M(-60.0%) | $180.43M(-52.0%) |
| Sep 2024 | - | $375.66M(+9.6%) |
| Jun 2024 | - | $342.79M(-25.2%) |
| Mar 2024 | - | $458.44M(+1.6%) |
| Dec 2023 | $451.17M | $451.17M(+41.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $318.17M(-36.6%) |
| Jun 2023 | - | $501.79M(+901.0%) |
| Mar 2023 | - | $50.13M(+26.9%) |
| Dec 2022 | $39.51M(+391.4%) | $39.51M(-4.1%) |
| Sep 2022 | - | $41.20M(-55.6%) |
| Jun 2022 | - | $92.71M(+1053.3%) |
| Dec 2021 | $8.04M | $8.04M |
FAQ
- What is MoonLake Immunotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual cash & cash equivalents year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly cash & cash equivalents year-on-year change?
What is MoonLake Immunotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MLTX is $180.43M
What is the all time high annual cash & cash equivalents for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash & cash equivalents is $451.17M
What is MoonLake Immunotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MLTX annual cash & cash equivalents has changed by -$270.74M (-60.01%)
What is MoonLake Immunotherapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MLTX is $271.57M
What is the all time high quarterly cash & cash equivalents for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash & cash equivalents is $501.79M
What is MoonLake Immunotherapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, MLTX quarterly cash & cash equivalents has changed by -$186.88M (-40.76%)